Previously we have reported the changes occurring in serum total alkaline phosphatase (ALP) activity and that of the bone isoenzyme (BS ALP) following tibial shaft fracture.' BS ALP activity, measured using the ISO-ALP kit (Boehringer Mannheim GmbH, Mannheim, Germany) which is based on wheat germ lectin precipitation, decreased significantly by the fourth day after injury reaching a nadir by day 8. Activity then increased progressively, reaching a concentration significantly higher than day I by week 10.
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In order to investigate whether these results represented a genuine decrease in the bone isoenzyme activity in response to fracture, we measured BS ALP in the same specimens using the immunoassay Alkphase-B (Metra Biosysterns (UK) Ltd, Oxford, UK).
MATERIALS AND METHODS
The subjects were 20 patients (19 male, 1 female) who had suffered isolated fractures of the tibia ±fibula. The age range was 16-65 years.
Recruitment to the study occurred within 24 h of injury. Samples of venous blood were collected on eight occasions following injury; within 24 h on days 4, 8, 14 and at weeks 5, 10, 14 and 20. Samples were separated within 15min of collection and the serum stored at -20°C until required.
The ISO-ALP kit uses wheat germ lectin to precipitate bone-selective ALP which can then be separated by centrifugation from the remaining serum isoenzymes in the supernatant. A total ALP activity (in an aliquot of untreated serum) and the residual activity (in the supernatant) Correspondence: Dr Shirley A Bowles.
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were measured on the EPPENDORF EPOS analyser 5060 using p-nitrophenylphosphate in a diethanolamine buffer at 37°C (BID-STAT Diagnostics), conforming to the recommendations of the German Society for Clinical Chemistry. The bone-selective activity is calculated using a nomogram supplied with the kit. On evaluation, the ISO-ALP kit has been shown to provide a convenient and reproducible means of determining bone-selective ALP. 2 Alkphase-B is an immunoassay which utilizes a monoclonal antibody against bone-specific ALP coated on a microtitre plate. The activity of the captured bone-specific enzyme is detected with a p-nitrophenylphosphate substrate incubated at room temperature. The performance characteristics of this assay and results with clinical samples have recently been reported.'
STATISTICAL ANALYSIS
The results were analysed using Friedman's two way analysis of variance and Wilcoxon's signed rank test with Bonferroni correction for multiple testing" (P' = kp where k is equal to number of comparisons made). Figure I shows the changes in bone-selective ALP measured by both methods. Using Friedman's test, there was a highly significant change in bone-selective ALP with time (P<O·OOI for both assays). The pattern of change observed with the immunoassay was very similar to that obtained using the ISO-ALP kit. In both cases, BS ALP fell significantly by day 4 (P' = 0-007) with a nadir at day 8. A significant increase over the initial BS ALP was observed somewhat earlier with this second assay-at week 5 altered glycosylation of the enzyme could account for reduced activity in both assays. However, it is also possible that these initial changes represent another example of the nonspecific acute phase response to injury. The increase in total ALP which occurred at the same time is also awaiting explanation.
RESULTS AND DISCUSSION
The changes in bone-selective ALP following tibial fracture reported previously have been confirmed using a second method. It is not clear whether the early decrease in activity found in these studies reflects a change in the quantity of enzyme present in serum under these circumstances or a failure of the assays to detect an altered enzyme structure. It would also be of interest to determine whether these changes are specific to fracture or also occur in response to injury of tissue other than bone. The early fall in BS ALP activity in these subjects following fracture is consistently found with two different methods of quantifying the bone isoenzyme. This may reflect a generalized suppression of bone formation and/or mineralization at a time when reorganization is occurring at the fracture site. However, osteocalcin, also an osteoblast product, did not show the same pattern of change in these subjects after injury.' Another possibility is that the nature of the enzyme present is altered in this early postinjury period. Wheat germ lectin precipitation depends on binding to glycosyl moities and, since it is the nature of post-translational glycosylation which distinguishes the bone and liver isoenzymes, it is quite likely that these differences are also exploited in the immunoassay. Therefore,
